Published in Women's Health Weekly, March 18th, 2004
Genzyme consolidated its capital structure on June 30, 2003, by eliminating its tracking stocks. Figures reported for 2003 represent results for Genzyme General in the first and second quarters of the year and for the entire corporation in the third and fourth quarters.
Net income for the fourth quarter was $66.7 million, or $0.29 per diluted share, compared with net income of $44.7 million, or $0.20 per diluted share, for the fourth quarter a year earlier. Excluding special items...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.